TET2, ANPM1 and FLT3-ITD Gene Mutations in Normal Karyotype Acute Myeloid Leukemia

被引:0
|
作者
Sun, Aining [1 ]
Tian, Xiaopeng [1 ]
Yin, Jia [1 ]
Li, Weiyang [1 ]
Chen, Suning [1 ]
Wu Depei [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Dept Hematol, Suzhou, Peoples R China
关键词
D O I
10.1182/blood.V120.21.1413.1413
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1413
引用
收藏
页数:2
相关论文
共 50 条
  • [21] RSK1 dependency in FLT3-ITD acute myeloid leukemia
    Kong, Tim
    Laranjeira, Angelo B. A.
    Letson, Christopher T.
    Yu, Layow
    He, Fan
    Jayanthan, Aarthi
    Los, Gerrit
    Dunn, Sandra E.
    Challen, Grant A.
    Oh, Stephen T.
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [22] TET2 GENE MUTATIONS IN CHILDREN SECONDARY ACUTE MYELOID LEUKEMIA
    Takun, Kira
    Lavrinenko, Victoria
    Barovskaya, Julia
    Filipovich, Tatyana
    HLA, 2017, 89 (06) : 476 - 477
  • [23] Specific pattern of protein expression in acute myeloid leukemia harboring FLT3-ITD mutations
    Scholl, Sebastian
    Melle, Christian
    Bleul, Annett
    Spies-Weisshart, Baerbel
    Kunert, Christa
    Hoffken, Klaus
    Von Eggeling, Ferdinand
    LEUKEMIA & LYMPHOMA, 2007, 48 (12) : 2418 - 2423
  • [24] Landscape of TET2 mutations in acute myeloid leukemia
    Weissmann, S.
    Alpermann, T.
    Grossmann, V.
    Kowarsch, A.
    Nadarajah, N.
    Eder, C.
    Dicker, F.
    Fasan, A.
    Haferlach, C.
    Haferlach, T.
    Kern, W.
    Schnittger, S.
    Kohlmann, A.
    LEUKEMIA, 2012, 26 (05) : 934 - 942
  • [25] Landscape of TET2 mutations in acute myeloid leukemia
    S Weissmann
    T Alpermann
    V Grossmann
    A Kowarsch
    N Nadarajah
    C Eder
    F Dicker
    A Fasan
    C Haferlach
    T Haferlach
    W Kern
    S Schnittger
    A Kohlmann
    Leukemia, 2012, 26 : 934 - 942
  • [26] CHARACTERIZATION AND PROGNOSTIC IMPACT OF FLT3-ITD MUTATIONS IN INTERMEDIATE RISK ACUTE MYELOID LEUKEMIA
    Amorim, M.
    Aguiar, E.
    Gomes, P.
    Lopes, M.
    Soares, M.
    Bastos, J.
    Damas, R.
    Gomes, M.
    Marini, C.
    Trigo, F.
    Guimaraes, J.
    HAEMATOLOGICA, 2016, 101 : 677 - 677
  • [27] Partnering with PARP inhibitors in acute myeloid leukemia with FLT3-ITD
    Dellomo, Anna J.
    Baer, Maria R.
    Rassool, Feyruz V.
    CANCER LETTERS, 2019, 454 : 171 - 178
  • [28] Impact of FLT3-ITD length on prognosis of acute myeloid leukemia
    Liu, Song-Bai
    Dong, Hao-Jie
    Bao, Xie-Bing
    Qiu, Qiao-Cheng
    Li, Hong-Zhi
    Shen, Hong-Jie
    Ding, Zi-Xuan
    Wang, Chao
    Chu, Xiao-Ling
    Yu, Jing-Qiu
    Tao, Tao
    Li, Zheng
    Tang, Xiao-Wen
    Chen, Su-Ning
    Wu, De-Pei
    Li, Ling
    Xue, Sheng-Li
    HAEMATOLOGICA, 2019, 104 (01) : E9 - E12
  • [29] Treatment Outcome of Acute Myeloid Leukemia Patients From Brazil According to Karyotype, Presence or Not of FLT3-ITD and NPM1 Mutations, and BAALC Gene Expression
    Lira Benicio, Mariana Tereza
    Tiburcio Ribeiro, Ana Flavia Leonardi
    Firmato Gloria, Ana Beatriz
    Lucena-Araujo, Antonio R.
    Santana-Lemos, Barbara A.
    Jacomo, Rafael
    Assumpcao, Juliana Godoy
    Oliveira, Fabio Morato
    Morato, Fabio
    Xavier, Sandra Guerra
    Fagundes, Evandro
    Rego, Eduardo M.
    BLOOD, 2010, 116 (21) : 1569 - 1570
  • [30] Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia
    Noguera, NI
    Ammatuna, E
    Zangrilli, D
    Lavorgna, S
    Divona, M
    Buccisano, F
    Amadori, S
    Mecucci, C
    Falini, B
    Lo-Coco, F
    LEUKEMIA, 2005, 19 (08) : 1479 - 1482